Heron Therapeutics, Inc. (HRTX): Price and Financial Metrics

HRTX POWR Grades

• Growth is the dimension where HRTX ranks best; there it ranks ahead of 75.16% of US stocks.
• The strongest trend for HRTX is in Growth, which has been heading up over the past 179 days.
• HRTX's current lowest rank is in the Quality metric (where it is better than 10.39% of US stocks).

HRTX Stock Summary

• HRTX's went public 34.61 years ago, making it older than 91.57% of listed US stocks we're tracking.
• With a year-over-year growth in debt of 548.06%, Heron Therapeutics Inc's debt growth rate surpasses 97.42% of about US stocks.
• Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for HRTX comes in at -25.94% -- higher than that of only 14.95% of stocks in our set.
• If you're looking for stocks that are quantitatively similar to Heron Therapeutics Inc, a group of peers worth examining would be CCXI, CLSN, HTBX, ABEO, and OLED.
• Visit HRTX's SEC page to see the company's official filings. To visit the company's web site, go to www.herontx.com.

HRTX Valuation Summary

• In comparison to the median Healthcare stock, HRTX's price/earnings ratio is 113.97% lower, now standing at -5.1.
• Over the past 243 months, HRTX's EV/EBIT ratio has gone down 11.1.
• Over the past 243 months, HRTX's EV/EBIT ratio has gone down 11.1.

Below are key valuation metrics over time for HRTX.

HRTX Growth Metrics

The year over year revenue growth rate now stands at -40.43%.
• Its 5 year net income to common stockholders growth rate is now at -75%.
• The 5 year net cashflow from operations growth rate now stands at -18.95%.

Over the past 34 months, HRTX's revenue has gone down $11,163,000.

The table below shows HRTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	86.346	-203.354	-220.683
2021-09-30	86.296	-210.65	-228.318
2021-06-30	83.031	-199.538	-234.138
2021-03-31	83.256	-193.823	-228.313
2020-12-31	88.638	-184.82	-227.278
2020-09-30	103.116	-159.243	-222.917

HRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• HRTX has a Quality Grade of D, ranking ahead of 9.05% of graded US stocks.
• HRTX's asset turnover comes in at 0.243 -- ranking 181st of 682 Pharmaceutical Products stocks.
• IBIO, COLL, and PTGX are the stocks whose asset turnover ratios are most correlated with HRTX.

The table below shows HRTX's key quality metrics over time.